Dollar Tree, Inc. (DLTR) Tops Q3 EPS by 4c; Raises FY11 Outlook
Tweet
Share
E-mailGet Alerts DLTR Hot Sheet
Price: $123.57 -1.43%
Revenue Growth %: +4.4%
Financial Fact:
Net sales: 5B
Today's EPS Names:
MFON, SICP, LBAS, More
Revenue Growth %: +4.4%
Financial Fact:
Net sales: 5B
Today's EPS Names:
MFON, SICP, LBAS, More
Join SI Premium – FREE
Dollar Tree, Inc. (NASDAQ: DLTR) reported Q3 EPS of $0.87, $0.04 better than the analyst estimate of $0.83. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.58 billion.
Dollar Tree, Inc. sees Q4 2011 EPS of $1.50-$1.57, versus the consensus of $1.54. Dollar Tree, Inc. sees Q4 2011 revenue of $1.89-$1.94 billion, versus the consensus of $1.91 billion.
Dollar Tree, Inc. sees FY2011 EPS of $3.94-$4.01, versus prior guidance of $3.82-$3.92 and the consensus of $3.95. Dollar Tree, Inc. sees FY2011 revenue of $6.57-$6.62 billion, versus prior guidance of $6.53-$6.62 billion and the consensus of $6.58 billion.
Dollar Tree, Inc. sees Q4 2011 EPS of $1.50-$1.57, versus the consensus of $1.54. Dollar Tree, Inc. sees Q4 2011 revenue of $1.89-$1.94 billion, versus the consensus of $1.91 billion.
Dollar Tree, Inc. sees FY2011 EPS of $3.94-$4.01, versus prior guidance of $3.82-$3.92 and the consensus of $3.95. Dollar Tree, Inc. sees FY2011 revenue of $6.57-$6.62 billion, versus prior guidance of $6.53-$6.62 billion and the consensus of $6.58 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LVMH achieves 3% organic revenue growth in the first quarter
- J&J's medical device sales fall short, cancer drugs seen growing
- Main Street Capital (MAIN) Reports Prelim Q1 Results
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
